Works matching IS 0008543X AND DT 2019 AND VI 125 AND IP 14


Results: 23
    1
    2
    3
    5
    6
    7
    8
    9
    10
    11
    12

    A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

    Published in:
    2019
    By:
    • Jones, Robin L.;
    • Chawla, Sant P.;
    • Attia, Steven;
    • Schöffski, Patrick;
    • Gelderblom, Hans;
    • Chmielowski, Bartosz;
    • Le Cesne, Axel;
    • Van Tine, Brian A.;
    • Trent, Jonathan C.;
    • Patel, Shreyaskumar;
    • Wagner, Andrew J.;
    • Chugh, Rashmi;
    • Heyburn, John W.;
    • Weil, Susan C.;
    • Wang, Wenquan;
    • Viele, Kert;
    • Maki, Robert G.
    Publication type:
    journal article
    13
    14
    15
    16
    17

    Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2-visit consent model.

    Published in:
    2019
    By:
    • Johnson, Liza‐Marie;
    • Sykes, April D.;
    • Lu, Zhaohua;
    • Valdez, Jessica M.;
    • Gattuso, Jami;
    • Gerhardt, Elsie;
    • Hamilton, Kayla V.;
    • Harrison, Lynn W.;
    • Hines‐Dowell, Stacy J.;
    • Jurbergs, Niki;
    • McGee, Rose B.;
    • Nuccio, Regina;
    • Ouma, Annastasia A.;
    • Pritchard, Michele;
    • Quinn, Emily A.;
    • Baker, Justin N.;
    • Mandrell, Belinda N.;
    • Nichols, Kim E.;
    • Johnson, Liza-Marie;
    • Hines-Dowell, Stacy J
    Publication type:
    journal article
    18
    19

    Daratumumab in multiple myeloma.

    Published in:
    2019
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Hofmeister, Craig C.;
    • Joseph, Nisha S.;
    • Heffner, Thomas L.;
    • Gupta, Vikas A.;
    • Sullivan, Harold C.;
    • Neish, Andrew S.;
    • Dhodapkar, Madhav V.;
    • Lonial, Sagar
    Publication type:
    journal article
    20

    A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.

    Published in:
    2019
    By:
    • Voss, Martin H.;
    • Bhatt, Rupal S.;
    • Vogelzang, Nicholas J.;
    • Fishman, Mayer;
    • Alter, Robert S.;
    • Rini, Brian I.;
    • Beck, J. Thaddeus;
    • Joshi, Monika;
    • Hauke, Ralph;
    • Atkins, Michael B.;
    • Burgess, Earle;
    • Logan, Theodore F.;
    • Shaffer, David;
    • Parikh, Rahul;
    • Moazzam, Nauman;
    • Zhang, Xiaosha;
    • Glasser, Chad;
    • Sherman, Matthew L.;
    • Plimack, Elizabeth R.
    Publication type:
    journal article
    21

    Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

    Published in:
    2019
    By:
    • Gunaratne, Preethi H.;
    • Pan, Yinghong;
    • Rao, Abhi K.;
    • Lin, Chunru;
    • Hernandez‐Herrera, Anadulce;
    • Liang, Ke;
    • Rait, Antonina S.;
    • Venkatanarayan, Avinashnarayan;
    • Benham, Ashley L.;
    • Rubab, Farwah;
    • Kim, Sang Soo;
    • Rajapakshe, Kimal;
    • Chan, Clara K.;
    • Mangala, Lingegowda S.;
    • Lopez‐Berestein, Gabriel;
    • Sood, Anil K.;
    • Rowat, Amy C.;
    • Coarfa, Cristian;
    • Pirollo, Kathleen F.;
    • Flores, Elsa R.
    Publication type:
    journal article
    22
    23

    Issue Information.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 14, p. 2327, doi. 10.1002/cncr.31614
    Publication type:
    Article